These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 5611519)

  • 1. [Glucose intolerance test in patients treated with estro-progestational drugs].
    Marazzini F; Schubert L
    Ann Ostet Ginecol Med Perinat; 1967 Nov; 89(11):742-52. PubMed ID: 5611519
    [No Abstract]   [Full Text] [Related]  

  • 2. [Electroencephalographic findings in patients treated by synthetic estroprogestinic preparations].
    Ferroni A; Marinelli M; Lauro V; Bergonzi P
    Arch Ostet Ginecol; 1969; 74(3):236-50. PubMed ID: 5402697
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of oral contraceptives on carbohydrate metabolism.
    Spellacy WN
    J Reprod Med; 1970 Jul; 5(1):20-4. PubMed ID: 5521767
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen therapy and glucose tolerance test.
    Di Paola G; Robín M; Nicholson R
    Am J Obstet Gynecol; 1970 May; 107(1):124-32. PubMed ID: 5448490
    [No Abstract]   [Full Text] [Related]  

  • 5. [Extragonadal endocrine repercussions of long-term estro-progestational treatment].
    Rozenbaum H; Netter A
    Actual Endocrinol (Paris); 1973; 13(0):73-8. PubMed ID: 4367475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Severe changes in the endometrium caused by prolonged action of an estro-progestational synergy administered orally].
    Marty G; Rey C
    Bull Fed Soc Gynecol Obstet Lang Fr; 1969; 21(5):538-40. PubMed ID: 5386405
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood glucose in women on Noracycline and Gestranol].
    Jabloński K; Giermańska T; Filc-Bauer A
    Pol Tyg Lek; 1972 Oct; 27(43):1676-8. PubMed ID: 4639621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Late cutaneous porphyria with sclerodermic syndrome revealed by taking estrogens, barbiturates and estro-progestational hormones].
    Durepaire-Fischer R; Goudal H; Bolgert M
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(3):281-4. PubMed ID: 5405291
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical study of a synthetic estro-progestational agent: FH 080].
    Villedieu P
    Presse Med (1893); 1966 Nov; 74(51):2625-6. PubMed ID: 5926994
    [No Abstract]   [Full Text] [Related]  

  • 10. Glucose intolerance during ethynodiol diacetate--mestranol therapy.
    Halling GR; Michals EL; Paulsen CA
    Metabolism; 1967 May; 16(5):465-8. PubMed ID: 6025024
    [No Abstract]   [Full Text] [Related]  

  • 11. [Colposcopic findings in women treated with oral estrogen-progestagens].
    Gacci G
    Quad Clin Ostet Ginecol; 1968 Dec; 23(12):1575-80. PubMed ID: 5744200
    [No Abstract]   [Full Text] [Related]  

  • 12. Investigations on the effect of an oral contraceptive and its components on liver function, serum proteins, copper, coeruloplasmin and gamma-glutamyl peptidase in postmenopausal women.
    Adlercreutz H; Eisalo A; Heino A; Luukkainen T; Penttilä I; Saukkonen H
    Scand J Gastroenterol; 1968; 3(3):273-84. PubMed ID: 4179181
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thromboelastographic changes in patients treated with an anovulatory drug with estro-progestinic action].
    Schubert L; Acerboni F; Gibelli A; Giarola P
    Minerva Ginecol; 1969 Oct; 21(19):1323-8. PubMed ID: 5407219
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study of a progestational hormone in low doses].
    Gaudefroy M
    Bull Fed Soc Gynecol Obstet Lang Fr; 1965; 17(5):442-3. PubMed ID: 5866398
    [No Abstract]   [Full Text] [Related]  

  • 15. [Apropos of the appearance of chloasma during treatment with synthetic progestational agents].
    Rivoire J
    Lyon Med; 1967 Mar; 217(13):954-5. PubMed ID: 6042243
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tolerance of the gestagen-estrogen combination Noracyclin in contraception and gynecologic indications].
    Willmes HG
    Med Klin; 1967 Jun; 62(24):951-4. PubMed ID: 5627276
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholestatic jaundice due to an estro-progestative drug preceding cholestatic jaundice of pregnancy].
    Dumont M; Karo G; Chambonnet R
    Bull Fed Soc Gynecol Obstet Lang Fr; 1971; 23(4):466-7. PubMed ID: 5153247
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of oral contraceptives on carbohydrate metabolism. Study by means of the oral glucose tolerance test].
    Reyes-Ceja L; Paniagua H; Torres I; Zárate A
    Ginecol Obstet Mex; 1969 Sep; 26(155):295-303. PubMed ID: 5402848
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatic function in subjects treated with estro-progestinic drugs].
    Scalzerle V; Laudanna Sclazerle A
    Minerva Ginecol; 1968 Feb; 20(4):371-4. PubMed ID: 5738735
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral contraceptive agents and the glucose tolerance problem.
    Cohn RE
    Pa Med; 1971 Jan; 74(1):62-4. PubMed ID: 5540284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.